# Archive

Canonical Atlas analysis: https://atlas-staging.minestarters.com/news/archive--2437f745-66c3-458a-8204-3b04939fb5b1

Original source: https://www.thenewswire.com/press-releases/1B2aFdvzP-voyageur-pharmaceuticals-advances-mueller-iodine-extraction-process-with-99-8-purity-results-and-planned-field-pilot-testing.html

Publisher: thenewswire

Original announcement: 2026-08-10T00:00:00.000Z

Analysis by Minestarters Atlas

Atlas analysis published: 2026-10-01T03:34:48.570Z

Atlas analysis updated: 2026-10-01T03:34:48.570Z

- Company: Voyageur Pharmaceuticals Ltd.

- Ticker: VM

- Exchange: TSXV

- Region: Texas

- Primary commodity: Iodine

- Secondary commodities: Barium

- Document categories: Metallurgy

- Extracted: 2026-10-01 03:34:49 UTC

Narrative sentiment: 0.80 · Bullish

## Minestarters Atlas summary

Voyageur Pharmaceuticals has successfully demonstrated its Mueller iodine extraction process in laboratory settings, achieving 99.8% purity and over 90% recovery from oilfield brine. The company is now preparing to deploy a mobile pilot unit for field testing in September 2026 to validate the process under real-world conditions.

Reasoning: Successful laboratory validation of a proprietary extraction process with high purity and recovery, moving toward real-world field testing.

- Positive factor: High purity iodine \(99.8%\) achieved in lab

- Positive factor: Strong recovery \(&gt;90%\) demonstrated

- Positive factor: Transitioning to field pilot testing

- Positive factor: Modular production concept for scale-up

Facts used in scoring: 1

## Classification and evidence

**High Recovery**

Polarity: positive

Definition: Recovery at or above the exceptional band for the commodity and processing route.

Why it applies: Laboratory recovery exceeded 90% for iodine.

Evidence · text

> overall process recovery exceeding 90%

**Bench Scale Only**

Polarity: negative

Definition: Only preliminary bench tests completed — no locked-cycle or pilot work.

Why it applies: Current results are from laboratory work, though moving to pilot stage.

Evidence · text

> Laboratory operations have demonstrated the process under controlled conditions

**Mill Route**

Polarity: neutral

Definition: Processing via mill or concentrator \(CIL, CIP, tank leach, flotation\).

Why it applies: the document describes a flotation route \("concentrate"\)

**Single Domain Only**

Polarity: negative

Definition: Testing limited to one composite or domain — representativeness not established.

Why it applies: only one composite was tested

## Extracted facts

Stored fact records: 1. Some facts used in scoring do not have a stored record.

## Metallurgical Results (1)

### laboratory

[Link to this fact](https://atlas-staging.minestarters.com/news/archive--2437f745-66c3-458a-8204-3b04939fb5b1#fact-metallurgical-facts-0)

Mueller process · iodine

#### Identity

- Project: Mueller process
- Commodity: iodine
- Region: texas
- Reported Region: Texas
- Ticker: VM

#### Test Work

- Program Status: preliminary
- Test Type: laboratory
- Processing Route: Mueller iodine extraction process
- Sample: laboratory work using real oilfield brine feed

#### Recovery

- Recovery: 90 %
- Conc. Grade: 99.8
- Conc. Grade Unit: % purity

#### Review

- Needs Review: No
- Historical: No

#### Dates

- Event date: 2026-08-10T00:00:00.000Z

Reasoning: High purity and recovery results in lab setting provide strong technical validation.

- Positive factor: 99.8% purity achieved

- Positive factor: Recovery &gt; 90%

Evidence · text

> Recent laboratory work has successfully produced iodine at 99.8% purity, with overall process recovery exceeding 90%.

## How Atlas produces this analysis

Minestarters Atlas uses automated extraction to summarize mining announcements, identify reported measurements, and classify supporting evidence. Sentiment reflects the extracted narrative and classification rules; it is an interpretation, not a reported measurement. Evidence quotes and context are provided where available. Missing data, low-confidence results, and review flags indicate limitations. Check the original publisher announcement before relying on an interpretation.
